All studies
RecruitingTherapeutic use (Phase IV)Interventional

The efficacy of the use of Cellular Matrix-BCT-HA (combination of autologous platelet-rich plasma and non-cross-linked hyaluronic acid) compared to local estrogen therapy (Blissel, estriol 50 micrograms/g vaginal gel) in women with genitourinary syndrome of menopause. A randomized controlled trial, with a second blind observer.

After the menopause, lower hormone levels often cause vaginal dryness, itching, burning, and pain during sex. Doctors call this genitourinary syndrome of menopause (GSM). This study aims to find out which of two treatments offers better relief over six months. Participants will receive either a standard hormone treatment (Blissel, a gentle oestrogen gel applied at home) or Cellular Matrix (a treatment combining hyaluronic acid, a natural moisturiser, with platelets taken from a small sample of your own blood). Platelets contain natural proteins that help tissues heal. Researchers will check vaginal health, tissue moisture, and symptom changes at three and six months. The results could give women and their doctors better evidence when choosing between hormone treatments and newer, non-hormonal alternatives.

At a glance

Status
Recruiting
Phase
Therapeutic use (Phase IV)
Sponsor
Santiago Dexeus Font Fundacio Privada
Enrolment target
192
Start
26 Apr 2024

What is this study about?

During and after the menopause, levels of the hormone oestrogen drop naturally. For many women, this causes the lining of the vagina to become thinner, drier, and less elastic. It can lead to uncomfortable symptoms such as burning, itching, frequent urinary discomfort, and pain during sex. Together, these issues are known as genitourinary syndrome of menopause (GSM).

The most common treatment is local oestrogen, such as Blissel gel, which is put directly into the vagina to restore moisture and rebuild the lining. While this works well for many, some women cannot use oestrogen treatments or prefer not to use hormones. This trial investigates a newer, non-hormonal approach called Cellular Matrix. It blends hyaluronic acid—a gel-like substance that naturally holds moisture in the body—with platelet-rich plasma, which is prepared from a small sample of your own blood and contains natural healing factors.

In this study, researchers want to see whether the blood-platelet and hyaluronic acid mixture works as well as, or better than, the standard oestrogen gel. By comparing tissue health, pH levels, and daily comfort over six months, the trial hopes to provide clear answers about whether this non-hormonal option is a helpful, reliable alternative.

Key takeaways

  • The trial compares a standard oestrogen gel with an injection made from your own blood platelets and hyaluronic acid.
  • The goal is to relieve vaginal dryness, burning, and pain during sex caused by the menopause.
  • Participants are followed up over a six-month period to measure improvements in tissue health and comfort.
  • A computer randomly decides which of the two treatments you receive.
  • Taking part is completely voluntary and you can withdraw at any time.

Who may be eligible?

This study is open to women who have gone through the menopause and are experiencing uncomfortable vaginal symptoms, such as persistent dryness, itching, irritation, or painful sex.

To take part, you will need to be able to attend follow-up visits over a six-month period and agree to standard, gentle examinations to check how your vaginal tissue is healing.

Certain factors may mean this trial is not suitable for you, such as having an active vaginal infection, untreated health conditions, or taking certain medicines that could interfere with the study treatments. A doctor on the research team will review your full medical history before you join.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am a woman who has gone through the menopause.
  2. I am troubled by symptoms such as vaginal dryness, burning, itching, or painful sex.
  3. I am able to attend clinic visits at three and six months.
  4. I am happy to undergo routine, gentle vaginal examinations and swab tests.
  5. I am willing to be placed into either the gel treatment or the platelet treatment group.
Answer every question to see your result.

What does participation involve?

Taking part in this study lasts for about six months. If you join, you will be placed into one of two treatment groups by chance (randomly):

• Group 1 uses Blissel gel, a low-dose oestrogen gel applied inside the vagina using an applicator at home as directed. • Group 2 receives Cellular Matrix, which involves having a small amount of blood taken from your arm. The clinic team prepares the platelets from your blood, mixes them with hyaluronic acid, and gently applies or injects the mixture into the vaginal tissue.

You will have check-up visits at the start of the study, at three months, and at six months. During these visits, the research team will carry out gentle vaginal examinations, test your natural pH levels, take small swabs to check cell health, and ask you to complete short questionnaires about your comfort, daily symptoms, and sexual wellbeing. You may also be asked to consent to close-up medical photographs to document tissue healing.

Potential risks and benefits

You may benefit from improved vaginal moisture, reduced soreness, and less discomfort during intimate moments, though improvement cannot be guaranteed. Risks with Blissel gel are usually mild and may include temporary local irritation or discharge. Risks with Cellular Matrix include brief discomfort or bruising from the blood draw, and slight soreness or minor bleeding where the treatment is applied. Joining this trial is entirely your choice, and you can change your mind and withdraw at any time without your regular medical care being affected.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Spain

Common questions

What is genitourinary syndrome of menopause (GSM)?

It is a common collection of symptoms caused by low oestrogen levels after menopause, including vaginal dryness, burning, itching, discomfort during sex, and urinary changes.

What is platelet-rich plasma (PRP)?

PRP is made by taking a small sample of your own blood and spinning it in a machine to concentrate the platelets. Platelets contain natural proteins that help body tissues repair themselves.

Can I choose which treatment I get?

No. A computer places participants into one of the two treatment groups by chance. This makes the comparison fair and scientifically reliable.

Will the examinations be painful?

The checks are similar to a standard smear test or routine gynaecological exam. The team will be gentle and work at your pace to keep you as comfortable as possible.

What happens if I decide to stop taking part?

You are free to leave the trial at any point. Your decision will not change the standard of NHS care you receive or your relationship with your healthcare team.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "The efficacy of the use of Cellular Matrix-BCT-HA (combinati…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.